Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8153 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8153 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8153 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8058 |
Intermediate Similarity |
NPD3705 |
Approved |
0.805 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7962 |
Intermediate Similarity |
NPD37 |
Approved |
0.7945 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7945 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7847 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7818 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7808 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7724 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7707 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7671 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7633 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7552 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7536 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7516 |
Intermediate Similarity |
NPD3382 |
Approved |
0.7516 |
Intermediate Similarity |
NPD3383 |
Approved |
0.7516 |
Intermediate Similarity |
NPD3384 |
Approved |
0.7483 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7456 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7421 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7389 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7383 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7379 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7362 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7325 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD1091 |
Approved |
0.731 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7308 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7251 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7233 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7184 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7115 |
Intermediate Similarity |
NPD3454 |
Phase 3 |
0.7108 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7103 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7102 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7086 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7086 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7078 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.707 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7069 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7062 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7051 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7048 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7047 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7044 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7043 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7029 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7024 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.6993 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD4538 |
Approved |
0.6987 |
Remote Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD4536 |
Approved |
0.6982 |
Remote Similarity |
NPD919 |
Approved |
0.698 |
Remote Similarity |
NPD5327 |
Phase 3 |
0.6977 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6977 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6977 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD3657 |
Discovery |
0.6964 |
Remote Similarity |
NPD3882 |
Suspended |
0.6962 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6962 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6959 |
Remote Similarity |
NPD1611 |
Approved |
0.6959 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6959 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6957 |
Remote Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD7124 |
Phase 2 |
0.6954 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD7819 |
Suspended |
0.6946 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6939 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6939 |
Remote Similarity |
NPD5126 |
Approved |
0.6933 |
Remote Similarity |
NPD6696 |
Suspended |
0.6933 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6903 |
Remote Similarity |
NPD3620 |
Phase 2 |
0.6903 |
Remote Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.6899 |
Remote Similarity |
NPD2796 |
Approved |
0.689 |
Remote Similarity |
NPD5976 |
Discontinued |
0.6879 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6879 |
Remote Similarity |
NPD6111 |
Discontinued |
0.6879 |
Remote Similarity |
NPD4481 |
Phase 3 |
0.6875 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.686 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6859 |
Remote Similarity |
NPD5735 |
Approved |
0.6859 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6859 |
Remote Similarity |
NPD1933 |
Approved |
0.6855 |
Remote Similarity |
NPD5762 |
Approved |
0.6855 |
Remote Similarity |
NPD5763 |
Approved |
0.6848 |
Remote Similarity |
NPD4210 |
Discontinued |
0.6839 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6835 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6832 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6832 |
Remote Similarity |
NPD3892 |
Phase 2 |
0.6832 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6832 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6828 |
Remote Similarity |
NPD6671 |
Approved |
0.6824 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6821 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6809 |
Remote Similarity |
NPD5006 |
Approved |
0.6809 |
Remote Similarity |
NPD5005 |
Approved |
0.6807 |
Remote Similarity |
NPD4005 |
Discontinued |
0.6805 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6796 |
Remote Similarity |
NPD6842 |
Approved |
0.6796 |
Remote Similarity |
NPD6841 |
Approved |
0.6796 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6792 |
Remote Similarity |
NPD6100 |
Approved |
0.6792 |
Remote Similarity |
NPD6099 |
Approved |
0.6772 |
Remote Similarity |
NPD7119 |
Phase 2 |
0.677 |
Remote Similarity |
NPD5177 |
Phase 3 |
0.6768 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6768 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6766 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6766 |
Remote Similarity |
NPD4678 |
Approved |
0.6766 |
Remote Similarity |
NPD4675 |
Approved |
0.6766 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6763 |
Remote Similarity |
NPD3051 |
Approved |
0.6761 |
Remote Similarity |
NPD8156 |
Discontinued |
0.6757 |
Remote Similarity |
NPD5691 |
Approved |
0.6755 |
Remote Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.6753 |
Remote Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.675 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.675 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.675 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.675 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.675 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6746 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6744 |
Remote Similarity |
NPD5677 |
Discontinued |
0.6736 |
Remote Similarity |
NPD5535 |
Approved |
0.6735 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6731 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.673 |
Remote Similarity |
NPD3748 |
Approved |
0.6728 |
Remote Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.6727 |
Remote Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.6724 |
Remote Similarity |
NPD2969 |
Approved |
0.6724 |
Remote Similarity |
NPD2970 |
Approved |
0.6712 |
Remote Similarity |
NPD6387 |
Discontinued |
0.6712 |
Remote Similarity |
NPD7157 |
Approved |
0.6708 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6707 |
Remote Similarity |
NPD1511 |
Approved |
0.6707 |
Remote Similarity |
NPD7212 |
Phase 2 |
0.6707 |
Remote Similarity |
NPD7213 |
Phase 3 |
0.6706 |
Remote Similarity |
NPD5402 |
Approved |
0.6705 |
Remote Similarity |
NPD8251 |
Approved |
0.6705 |
Remote Similarity |
NPD8099 |
Discontinued |
0.6705 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6705 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6705 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6705 |
Remote Similarity |
NPD8252 |
Approved |
0.6703 |
Remote Similarity |
NPD7243 |
Clinical (unspecified phase) |
0.669 |
Remote Similarity |
NPD2684 |
Approved |
0.6688 |
Remote Similarity |
NPD4140 |
Approved |
0.6687 |
Remote Similarity |
NPD2438 |
Suspended |
0.6687 |
Remote Similarity |
NPD2161 |
Phase 2 |
0.6686 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6685 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6684 |
Remote Similarity |
NPD4420 |
Approved |
0.6667 |
Remote Similarity |
NPD3496 |
Discontinued |
0.6667 |
Remote Similarity |
NPD5111 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD4236 |
Phase 3 |
0.6667 |
Remote Similarity |
NPD5109 |
Approved |
0.6667 |
Remote Similarity |
NPD5110 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD1139 |
Approved |
0.6667 |
Remote Similarity |
NPD4237 |
Approved |
0.6667
|
Remote Similarity |
NPD2200 |
Suspended |